Skip to content

Primary Biliary Cholangitis 4 C3280201

Published: July 22, 2026Updated: August 27, 2026

A form of autoimmune liver disease targeting bile ducts. It predominantly affects women and can cause scarring of the liver. Early treatment helps manage symptoms and slow disease progression.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ascites

Generalized symptoms

(hepatobiliary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Itchy skin

(hepatobiliary)

Right upper quadrant discomfort

(hepatobiliary)

Spider angiomata

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Ursodeoxycholic acid (UDCA)

First-line bile acid therapy that helps protect liver cells and improve bile flow. This treatment is the cornerstone of PBC management and has been shown to slow disease progression in most patients.

medication
3

Alcohol avoidance and liver protection

Complete abstinence from alcohol and avoidance of hepatotoxic substances. A healthy lifestyle supports liver function and prevents additional injury to hepatic tissue.

lifestyle

Additional treatment options

Obeticholic acid (second-line)

An alternative or adjunctive bile acid therapy for patients who respond inadequately to UDCA alone. This FXR agonist helps reduce bile acid toxicity and inflammation in liver tissue.

medication

Low-sodium, balanced nutrition

Dietary modification to reduce sodium intake and maintain adequate protein consumption. Proper nutrition helps manage ascites and supports overall liver function.

dietary

Regular hepatic function surveillance

Scheduled blood tests and imaging to monitor disease progression, treatment response, and development of complications such as portal hypertension or hepatocellular carcinoma.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Primary Biliary Cholangitis 4 C3280201?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lindor KD, Bowlus CL, Boyer J, et al. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019.

guideline2019
2

Hirschfield GM, Gershwin ME. The immunopathology of primary biliary cholangitis. Clin Liver Dis. 2022.

review2022
3

Nevens F, Andreone P, Mazzella G, et al. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. N Engl J Med. 2016.

clinical_trial2016
4

Zhang Y, Li G, He Q, et al. Efficacy and Safety of Obeticholic Acid for Treatment of Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. J Hepatol. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Primary Biliary Cholangitis 4 C3280201. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy